Aprea Therapeutics (APRE)
(Delayed Data from NSDQ)
$3.30 USD
+0.08 (2.48%)
Updated Aug 13, 2024 03:59 PM ET
After-Market: $3.34 +0.04 (1.21%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.65 |
EPS Last Quarter | -0.58 |
Last EPS Surprise | 9.38% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.57 |
Next Year | -0.78 |
EPS (TTM) | -3.03 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.15M | 0.17M | 0.80M | 0.80M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.15M | 0.17M | 0.80M | 0.80M |
Low Estimate | 0.15M | 0.17M | 0.80M | 0.80M |
Year ago Sales | 0.32M | 0.01M | 0.58M | 0.80M |
Year over Year Growth Est. | -53.13% | 1,600.00% | 37.22% | 0.00% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.65 | -0.64 | -2.57 | -0.78 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.64 | -0.65 | -2.57 | -0.78 |
High Estimate | -0.56 | -0.50 | -2.25 | -0.50 |
Low Estimate | -0.73 | -0.78 | -2.89 | -1.05 |
Year ago EPS | -0.86 | -0.92 | -3.95 | -2.57 |
Year over Year Growth Est. | 24.42% | 30.43% | 34.94% | 69.84% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.65 | -0.64 | -2.57 | -0.78 |
7 Days Ago | -0.65 | -0.64 | -2.57 | -0.78 |
30 Days Ago | -0.65 | -0.64 | -2.57 | -0.78 |
60 Days Ago | -0.65 | -0.64 | -2.57 | -0.78 |
90 Days Ago | -0.65 | -0.64 | -2.57 | -0.78 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.65 | -0.64 | -2.57 | -0.78 |
Zacks Consensus Estimate | -0.65 | -0.64 | -2.57 | -0.78 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.58 | -0.67 | -0.92 | -0.86 | NA |
Estimate | -0.64 | -0.78 | -0.56 | -1.08 | NA |
Difference | 0.06 | 0.11 | -0.36 | 0.22 | 0.01 |
Surprise | 9.38% | 14.10% | -64.29% | 20.37% | -5.11% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more